I'm LongbridgeAI, I can summarize articles.China Risun Group expects H1 2026 net profit to surge at least 335% year-on-year. This growth is driven by widened margins in refined chemicals, with caprolactam prices rising 13.3%, and a 78.5% revenue jump for the acquired Binhai Energy unit. The prior-year baseline was reduced by approximately RMB 36 million due to accounting restatements from the Binhai Energy acquisition.
- China Risun expects net profit for the six months ended June 30, 2026 to rise at least 335% from a year earlier. * Refined chemicals margins widened as caprolactam average selling price rose 13.3% to RMB 9,701.3/ton while pure benzene input costs stayed flat. * Binhai Energy acquisition led to a common-control restatement, cutting the prior-year period net profit by about RMB 36 million. * Binhai Energy six-month operating revenue jumped 78.5% to about RMB 419.3 million; its 150MW wind project began full-line transmission on Aug. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Risun Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260810-12278839), on August 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)